Press Releases

Loxo Oncology Announces Date of 2015 Program Guidance Webcast and Conference Call

STAMFORD, Conn., Feb. 23, 2015 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company focused on the discovery, development, and commercialization of targeted cancer therapies, today announced that the Company's management team will host a webcast and conference call on Monday, March 2, 2015 at 8:00 am ET to discuss the Company's program guidance for 2015. The call can be accessed by dialing (877) 930-8065 (domestic) or (253) 336-8041 (international) ten minutes prior to the start of the call and providing passcode 83819942.

A live webcast of the presentation will be available at http://ir.loxooncology.com/. A replay of the webcast will be available shortly after the conclusion of the call and archived on the Company's website for 30 days following the call.

About Loxo Oncology

Loxo Oncology is committed to the discovery, development, and commercialization of targeted cancer therapies with best-in-class potential. Our diverse pipeline reflects the convergence of proven therapeutic technologies with emerging insights into the underlying susceptibilities of cancer and drug resistance. We partner with leaders in academia and industry, allowing our management team to focus on clinical-regulatory execution in well-defined patient populations. www.loxooncology.com.

Contacts
Company:
Jacob S. Van Naarden
Vice President, Corporate Development and Strategy
jake@loxooncology.com
 
Investors:
Peter Rahmer
The Trout Group, LLC
646-378-2973
prahmer@troutgroup.com
 
Media:
Karen Sharma
MacDougall Biomedical Communications
781-235-3060
ksharma@macbiocom.com
Loxo Oncology